Breaking News Instant updates and real-time market news.

XLP

Consumer Staples Sector SPDR

$73.83 /

-0.745 (-1.00%)

08:25
01/06/23
01/06
08:25
01/06/23
08:25

Consumer Staples Sector SPDR: Pivot points

The following are the pivot points for the . Pivot High: $74.148, Pivot Low: $73.323. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Direct Line Insurance downgraded to Underweight from Equal Weight at Barclays » 06:00
02/03/23
02/03
06:00
02/03/23
06:00
DIISY

Direct Line Insurance

$9.10 /

+0.47 (+5.45%)

Barclays analyst Ivan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIISY Direct Line Insurance
$9.10 /

+0.47 (+5.45%)

01/30/23 Berenberg
Direct Line Insurance price target lowered to 159 GBp from 160 GBp at Berenberg
01/25/23 Berenberg
Direct Line Insurance downgraded to Hold from Buy at Berenberg
01/24/23 UBS
Direct Line Insurance price target lowered to 190 GBp from 194 GBp at UBS
01/24/23 Citi
Direct Line Insurance downgraded to Sell from Neutral at Citi
Hot Stocks
Creative Media & Community Trust acquires three multifamily assets » 05:59
02/03/23
02/03
05:59
02/03/23
05:59
CMCT

Creative Media & Community Trust

$5.36 /

-0.03 (-0.56%)

CMCT announced that it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMCT Creative Media & Community Trust
$5.36 /

-0.03 (-0.56%)

CMCT Creative Media & Community Trust
$5.36 /

-0.03 (-0.56%)

09/29/22 Edward Jones
CIM Commercial Trust initiated with a Buy at Edward Jones
Recommendations
MAA price target raised to $190 from $180 at JMP Securities » 05:58
02/03/23
02/03
05:58
02/03/23
05:58
MAA

MAA

$173.90 /

+5.49 (+3.26%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAA MAA
$173.90 /

+5.49 (+3.26%)

MAA MAA
$173.90 /

+5.49 (+3.26%)

01/17/23 Truist
MAA downgraded to Hold from Buy at Truist
01/11/23 BTIG
MAA price target lowered to $175 from $225 at BTIG
01/09/23 Credit Suisse
MAA downgraded to Neutral from Outperform at Credit Suisse
01/03/23 Jefferies
Independence Realty Trust downgraded at Jefferies on macro concerns
MAA MAA
$173.90 /

+5.49 (+3.26%)

Upgrade
H.B. Fuller upgraded to Buy from Neutral at Citi » 05:58
02/03/23
02/03
05:58
02/03/23
05:58
FUL

H.B. Fuller

$73.22 /

+2.91 (+4.14%)

Citi analyst Eric Petrie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FUL H.B. Fuller
$73.22 /

+2.91 (+4.14%)

FUL H.B. Fuller
$73.22 /

+2.91 (+4.14%)

01/23/23 Citi
H.B. Fuller price target raised to $72 from $65 at Citi
01/20/23 Deutsche Bank
H.B. Fuller price target raised to $78 from $72 at Deutsche Bank
01/20/23 Baird
H.B. Fuller price target lowered to $80 from $85 at Baird
10/13/22 Baird
H.B. Fuller margins biased higher despite macro evironment, says Baird
FUL H.B. Fuller
$73.22 /

+2.91 (+4.14%)

FUL H.B. Fuller
$73.22 /

+2.91 (+4.14%)

Hot Stocks
XPeng launches G9 SUV, P7 sports sedan in European markets » 05:57
02/03/23
02/03
05:57
02/03/23
05:57
XPEV

XPeng

$11.05 /

-0.09 (-0.81%)

XPeng launched its two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$11.05 /

-0.09 (-0.81%)

XPEV XPeng
$11.05 /

-0.09 (-0.81%)

01/11/23 JPMorgan
XPeng downgraded to Neutral from Overweight at JPMorgan
01/06/23 BofA
XPeng downgraded to Neutral at BofA after Tesla price cuts
01/06/23 BofA
XPeng downgraded to Neutral from Buy at BofA
01/04/23 Wedbush
Demand issues, Twitter focus creates 'perfect storm' for Tesla, says Wedbush
XPEV XPeng
$11.05 /

-0.09 (-0.81%)

XPEV XPeng
$11.05 /

-0.09 (-0.81%)

XPEV XPeng
$11.05 /

-0.09 (-0.81%)

XPEV XPeng
$11.05 /

-0.09 (-0.81%)

Downgrade
Repare Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley » 05:55
02/03/23
02/03
05:55
02/03/23
05:55
RPTX

Repare Therapeutics

$13.16 /

+0.62 (+4.94%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPTX Repare Therapeutics
$13.16 /

+0.62 (+4.94%)

RPTX Repare Therapeutics
$13.16 /

+0.62 (+4.94%)

11/17/22 H.C. Wainwright
Repare Therapeutics price target lowered to $25 from $38 at H.C. Wainwright
06/06/22 H.C. Wainwright
Repare Therapeutics price target lowered to $38 from $54 at H.C. Wainwright
06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
04/12/22 Stifel
Stifel downgrades Repare Therapeutics after 'blow to synthetic lethality thesis'
RPTX Repare Therapeutics
$13.16 /

+0.62 (+4.94%)

General news
Energy Action: » 05:55
02/03/23
02/03
05:55
02/03/23
05:55
$ECON

Economic Data

/

+

Energy Action: Oil prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Neurocrine upgraded to Overweight from Equal Weight at Morgan Stanley » 05:54
02/03/23
02/03
05:54
02/03/23
05:54
NBIX

Neurocrine

$107.96 /

-2.045 (-1.86%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NBIX Neurocrine
$107.96 /

-2.045 (-1.86%)

NBIX Neurocrine
$107.96 /

-2.045 (-1.86%)

12/13/22 RBC Capital
Neurocrine CAH data appears pushed back, says RBC Capital
11/14/22 Evercore ISI
Neurocrine downgraded to In Line from Outperform at Evercore ISI
11/02/22 BMO Capital
Neurocrine price target raised to $101 from $78 at BMO Capital
11/02/22 Wells Fargo
Neurocrine price target raised to $120 from $110 at Wells Fargo
NBIX Neurocrine
$107.96 /

-2.045 (-1.86%)

NBIX Neurocrine
$107.96 /

-2.045 (-1.86%)

Downgrade
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley » 05:53
02/03/23
02/03
05:53
02/03/23
05:53
IMRX

Immuneering

$4.16 /

+0.05 (+1.22%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMRX Immuneering
$4.16 /

+0.05 (+1.22%)

IMRX Immuneering
$4.16 /

+0.05 (+1.22%)

12/20/22 Piper Sandler
Piper recommends 'down market cap' biotech exposure for 2023
09/30/22 Piper Sandler
Immuneering transitions to clinical stage with IND approval, says Piper Sandler
07/25/22 Piper Sandler
Immuneering CFO departure not a 'red flag,' says Piper Sandler
07/08/22 Chardan
Immuneering initiated with a Buy at Chardan
IMRX Immuneering
$4.16 /

+0.05 (+1.22%)

Earnings
Sanofi sees 2023 business EPS up at low single digit rate at CER » 05:53
02/03/23
02/03
05:53
02/03/23
05:53
SNY

Sanofi

$47.22 /

-1.505 (-3.09%)

Sanofi expects 2023…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

01/31/23 Berenberg
Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/16/22 Goldman Sachs
Sanofi reinstated with a Buy at Goldman Sachs
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

Upgrade
Esperion upgraded to Equal Weight from Underweight at Morgan Stanley » 05:52
02/03/23
02/03
05:52
02/03/23
05:52
ESPR

Esperion

$5.91 /

-0.49 (-7.66%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESPR Esperion
$5.91 /

-0.49 (-7.66%)

ESPR Esperion
$5.91 /

-0.49 (-7.66%)

12/07/22 H.C. Wainwright
H.C. Wainwright bullish on Esperion as CLEAR Outcomes meets primary endpoint
08/03/22 Credit Suisse
Esperion downgraded to Underperform from Neutral at Credit Suisse
05/04/22 JPMorgan
Esperion upgraded to Neutral on achievable estimates at JPMorgan
05/04/22 JPMorgan
Esperion upgraded to Neutral from Underweight at JPMorgan
ESPR Esperion
$5.91 /

-0.49 (-7.66%)

ESPR Esperion
$5.91 /

-0.49 (-7.66%)

ESPR Esperion
$5.91 /

-0.49 (-7.66%)

Earnings
Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER » 05:52
02/03/23
02/03
05:52
02/03/23
05:52
SNY

Sanofi

$47.22 /

-1.505 (-3.09%)

IFRS EPS for Q4 was EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

01/31/23 Berenberg
Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/16/22 Goldman Sachs
Sanofi reinstated with a Buy at Goldman Sachs
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

SNY Sanofi
$47.22 /

-1.505 (-3.09%)

Upgrade
Erasca upgraded to Overweight from Equal Weight at Morgan Stanley » 05:51
02/03/23
02/03
05:51
02/03/23
05:51
ERAS

Erasca

$4.16 /

+0.165 (+4.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERAS Erasca
$4.16 /

+0.165 (+4.13%)

ERAS Erasca
$4.16 /

+0.165 (+4.13%)

  • 09
    Dec
ERAS Erasca
$4.16 /

+0.165 (+4.13%)

Downgrade
Cyteir downgraded to Underweight from Equal Weight at Morgan Stanley » 05:50
02/03/23
02/03
05:50
02/03/23
05:50
CYT

Cyteir Therapeutics

$1.61 /

+0.02 (+1.26%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYT Cyteir Therapeutics
$1.61 /

+0.02 (+1.26%)

CYT Cyteir Therapeutics
$1.61 /

+0.02 (+1.26%)

01/30/23 BofA
Cyteir Therapeutics downgraded to Neutral at BofA after strategic prioritization
01/30/23 BofA
Cyteir Therapeutics downgraded to Neutral from Buy at BofA
01/20/23 JPMorgan
Cyteir Therapeutics downgraded to Neutral from Overweight at JPMorgan
09/09/22 Morgan Stanley
Cyteir downgraded at Morgan Stanley with time needed for data
CYT Cyteir Therapeutics
$1.61 /

+0.02 (+1.26%)

Downgrade
Meta Platforms downgraded to Reduce from Hold at HSBC » 05:48
02/03/23
02/03
05:48
02/03/23
05:48
META

Meta Platforms

$188.78 /

+35.675 (+23.30%)

HSBC analyst Nicolas…

HSBC analyst Nicolas Cote-Colisson downgraded Meta Platforms to Reduce from Hold with an unchanged price target of $110. The company's Q4 results showed higher engagement, but revenue was still down, the analyst tells investors in a research note. The firm says headwinds for the company include the macro environment, competition and regulation versus one "longer-term tailwind that is Meta's lead in Metaverse." The recent share rally leads HSBC to downgrade the shares to Reduce.

ShowHide Related Items >><<
META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

05:13 Today DZ Bank
Meta Platforms upgraded to Hold from Sell at DZ Bank
02/02/23 Deutsche Bank
Meta Platforms price target raised to $200 from $125 at Deutsche Bank
02/02/23 RBC Capital
Meta Platforms price target raised to $225 from $160 at RBC Capital
02/02/23 Needham
Meta Platforms reported fundamentals still deteriorating, says Needham
META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

Periodicals
Tesla's sales of China-made EVs up 10% y/y in January, Reuters reports » 05:44
02/03/23
02/03
05:44
02/03/23
05:44
TSLA

Tesla

$188.32 /

+7.05 (+3.89%)

Tesla sold 66,051…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$188.32 /

+7.05 (+3.89%)

TSLA Tesla
$188.32 /

+7.05 (+3.89%)

01/30/23 Bernstein
Bernstein sees orders as 'most critical' to Tesla stock
01/30/23 Berenberg
Tesla upgraded to Buy from Hold at Berenberg
01/26/23 Morgan Stanley
Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley
01/26/23 Wedbush
Tesla price target raised to $200 from $175 at Wedbush
TSLA Tesla
$188.32 /

+7.05 (+3.89%)

TSLA Tesla
$188.32 /

+7.05 (+3.89%)

TSLA Tesla
$188.32 /

+7.05 (+3.89%)

TSLA Tesla
$188.32 /

+7.05 (+3.89%)

Downgrade
Stifel downgrades C.H. Robinson to Hold after 'sizable miss' » 05:43
02/03/23
02/03
05:43
02/03/23
05:43
CHRW

C.H. Robinson

$104.37 /

+2.36 (+2.31%)

Stifel analyst J. Bruce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

05:22 Today Stifel
C.H. Robinson downgraded to Hold from Buy at Stifel
02/02/23 BMO Capital
C.H. Robinson price target lowered to $85 from $90 at BMO Capital
02/02/23 Susquehanna
C.H. Robinson price target raised to $86 from $83 at Susquehanna
02/02/23 Wells Fargo
C.H. Robinson price target raised to $95 from $86 at Wells Fargo
CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

Downgrade
RBC downgrades Spirit AeroSystems on supply chain issues » 05:40
02/03/23
02/03
05:40
02/03/23
05:40
SPR

Spirit AeroSystems

$36.06 /

-0.08 (-0.22%)

RBC Capital analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPR Spirit AeroSystems
$36.06 /

-0.08 (-0.22%)

SPR Spirit AeroSystems
$36.06 /

-0.08 (-0.22%)

05:08 Today RBC Capital
Spirit AeroSystems downgraded to Sector Perform from Outperform at RBC Capital
01/09/23 Truist
Spirit AeroSystems price target raised to $42 from $39 at Truist
11/11/22 BofA
BofA double downgrades '737 story' Spirit AeroSystems to Underperform
11/11/22 BofA
Spirit AeroSystems downgraded to Underperform from Buy at BofA
SPR Spirit AeroSystems
$36.06 /

-0.08 (-0.22%)

SPR Spirit AeroSystems
$36.06 /

-0.08 (-0.22%)

SPR Spirit AeroSystems
$36.06 /

-0.08 (-0.22%)

Upgrade
Publicis upgraded to Overweight from Equal Weight at Barclays » 05:24
02/03/23
02/03
05:24
02/03/23
05:24
PUBGY

Publicis

$19.20 /

+0.822 (+4.47%)

Barclays analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PUBGY Publicis
$19.20 /

+0.822 (+4.47%)

PUBGY Publicis
$19.20 /

+0.822 (+4.47%)

01/31/23 Barclays
Publicis price target raised to EUR 68 from EUR 62.50 at Barclays
01/06/23 UBS
Publicis price target raised to EUR 71 from EUR 68 at UBS
12/16/22 Morgan Stanley
Publicis price target raised to EUR 53 from EUR 50 at Morgan Stanley
12/12/22 JPMorgan
Publicis price target raised to EUR 82 from EUR 75 at JPMorgan
Downgrade
C.H. Robinson downgraded to Hold from Buy at Stifel » 05:22
02/03/23
02/03
05:22
02/03/23
05:22
CHRW

C.H. Robinson

$104.37 /

+2.36 (+2.31%)

Stifel analyst J. Bruce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

02/02/23 BMO Capital
C.H. Robinson price target lowered to $85 from $90 at BMO Capital
02/02/23 Susquehanna
C.H. Robinson price target raised to $86 from $83 at Susquehanna
02/02/23 Wells Fargo
C.H. Robinson price target raised to $95 from $86 at Wells Fargo
02/02/23 Bernstein
C.H. Robinson price target lowered to $92 from $110 at Bernstein
CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

CHRW C.H. Robinson
$104.37 /

+2.36 (+2.31%)

Downgrade
Sallie Mae downgraded to Equal Weight from Overweight at Wells Fargo » 05:20
02/03/23
02/03
05:20
02/03/23
05:20
SLM

Sallie Mae

$14.82 /

-2.965 (-16.67%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLM Sallie Mae
$14.82 /

-2.965 (-16.67%)

SLM Sallie Mae
$14.82 /

-2.965 (-16.67%)

01/10/23 JPMorgan
Sallie Mae price target raised to $18 from $17 at JPMorgan
01/06/23 Barclays
Sallie Mae price target raised to $22 from $20 at Barclays
11/11/22 Compass Point
Sallie Mae downgraded to Neutral at Compass Point following outperformance
11/10/22 Compass Point
Sallie Mae downgraded to Neutral from Buy at Compass Point
SLM Sallie Mae
$14.82 /

-2.965 (-16.67%)

SLM Sallie Mae
$14.82 /

-2.965 (-16.67%)

SLM Sallie Mae
$14.82 /

-2.965 (-16.67%)

Downgrade
Cognizant downgraded to Neutral from Outperform at Baird » 05:19
02/03/23
02/03
05:19
02/03/23
05:19
CTSH

Cognizant

$70.62 /

+1.78 (+2.59%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$70.62 /

+1.78 (+2.59%)

CTSH Cognizant
$70.62 /

+1.78 (+2.59%)

01/19/23 MoffettNathanson
Cognizant downgraded to Underperform from Market Perform at MoffettNathanson
01/15/23 UBS
Cognizant price target raised to $68 from $62 at UBS
01/13/23 BMO Capital
Cognizant price target raised to $71 from $65 at BMO Capital
01/09/23 BofA
Cognizant downgraded to Underperform from Neutral at BofA
CTSH Cognizant
$70.62 /

+1.78 (+2.59%)

CTSH Cognizant
$70.62 /

+1.78 (+2.59%)

CTSH Cognizant
$70.62 /

+1.78 (+2.59%)

Upgrade
Lundin Mining upgraded to Overweight from Equal Weight at Morgan Stanley » 05:19
02/03/23
02/03
05:19
02/03/23
05:19
LUNMF

Lundin Mining

$7.32 /

-0.28 (-3.68%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LUNMF Lundin Mining
$7.32 /

-0.28 (-3.68%)

LUNMF Lundin Mining
$7.32 /

-0.28 (-3.68%)

02/02/23 Credit Suisse
Lundin Mining price target raised to C$10.25 from C$8.25 at Credit Suisse
01/23/23 JPMorgan
Lundin Mining price target lowered to SEK 57 from SEK 65 at JPMorgan
01/18/23 Scotiabank
Lundin Mining price target raised to C$15 from C$12 at Scotiabank
01/17/23 Scotiabank
Lundin Mining price target lowered to C$9 from C$10 at Scotiabank
Downgrade
Aptiv downgraded to Peer Perform from Outperform at Wolfe Research » 05:16
02/03/23
02/03
05:16
02/03/23
05:16
APTV

Aptiv

$118.67 /

+3.97 (+3.46%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$118.67 /

+3.97 (+3.46%)

APTV Aptiv
$118.67 /

+3.97 (+3.46%)

01/23/23 Deutsche Bank
Aptiv named short-term buy idea at Deutsche Bank
01/19/23 Deutsche Bank
Deutsche Bank keeps Buy on Aptiv, lowers price target to $126
01/09/23 BofA
Aptiv downgraded to Neutral from Buy at BofA
12/15/22 RBC Capital
Aptiv price target lowered to $115 from $120 at RBC Capital
APTV Aptiv
$118.67 /

+3.97 (+3.46%)

APTV Aptiv
$118.67 /

+3.97 (+3.46%)

Upgrade
Meta Platforms upgraded to Hold from Sell at DZ Bank » 05:13
02/03/23
02/03
05:13
02/03/23
05:13
META

Meta Platforms

$188.78 /

+35.675 (+23.30%)

DZ Bank analyst Ingo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

02/02/23 Deutsche Bank
Meta Platforms price target raised to $200 from $125 at Deutsche Bank
02/02/23 RBC Capital
Meta Platforms price target raised to $225 from $160 at RBC Capital
02/02/23 Needham
Meta Platforms reported fundamentals still deteriorating, says Needham
02/02/23 Jefferies
Meta Platforms price target raised to $225 from $175 at Jefferies
META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

META Meta Platforms
$188.78 /

+35.675 (+23.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.